Literature DB >> 1528607

Anaphylaxis in immunotherapy.

W E Davis, P R Cook, J P McKinsey, J W Templer.   

Abstract

Although anaphylactic reactions resulting from immunotherapy rarely occur, when they do occur they can be life-threatening. The literature reveals more than 30 deaths attributed to immunotherapy but numerous reports of anaphylaxis. We reviewed a 5-year experience of immunotherapy in a University practice and their experience with systemic reactions is presented. More than 125,000 injections were given in this time period. Of the 550 patients receiving immunotherapy, 14% experienced anaphylactic reactions, the majority of which were mild.

Entities:  

Mesh:

Year:  1992        PMID: 1528607     DOI: 10.1177/019459989210700112

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  The safety of self-administered allergen immunotherapy during the buildup and maintenance phases.

Authors:  Frederick M Schaffer; Andrew R Naples; Myla Ebeling; Thomas C Hulsey; Larry M Garner
Journal:  Int Forum Allergy Rhinol       Date:  2014-12-04       Impact factor: 3.858

2.  Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients.

Authors:  Diego Saporta
Journal:  J Environ Public Health       Date:  2012-02-20

3.  Changes in Peak Flow value during immunotherapy administration.

Authors:  Diego Saporta
Journal:  J Environ Public Health       Date:  2012-02-07

4.  The efficacy assessment of a self-administered immunotherapy protocol.

Authors:  Frederick M Schaffer; Larry M Garner; Myla Ebeling; Jeffrey M Adelglass; Thomas C Hulsey; Andrew R Naples
Journal:  Int Forum Allergy Rhinol       Date:  2015-10-14       Impact factor: 3.858

Review 5.  Sublingual Immunotherapy: A Useful Tool for the Allergist in Private Practice.

Authors:  Diego Saporta
Journal:  Biomed Res Int       Date:  2016-05-31       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.